Skip to Content

Why Analytical Method Validation is Required - Course 2018

Start Date:
Thursday, 5 April, 2018
End Date:
Friday, 6 April, 2018 6:00pm
Health & Nutrition

Course "A Risk Based Strategy for the Development & Validation of and Validation of Analytical Methods with a QbD Approach" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion. Overview: Following the initial development, the steps further continues thru optimization and subsequently to Validation, leading to the understanding of Validation Parameters and their generic definitions.

Guidance from EP, USP, ICH Q2 (R)1, AOAC etc. will be discussed. The presentation continually builds on from a conceptual level to practical applications leading to data handling, Data Integrity, Validation Protocol and other documentation, vis-a-vis Regulatory requirements. Discussions provide extensive guidance for preparing Methods Validation Protocols for the various stages of regulatory submissions, e.g. IND, NDA, ANDA, PAI, CMC etc.

Various aspects of Laboratory Controls (CGMP), QC procedures, SOPs that cover calibration, standardization, Qualification and Validation, will be included, along with statistical tools, SQC, SPC for processing and monitoring of analytical data. Strategies for the development Stability indicating assays will be touched along with a discussion on Methods Transfer, Spec setting, QC Batch Release, Potency Assays etc.

Why you should attend: "For various Analytical and Test Methods, a goal oriented pathway with proper design prior to development activities will help build Quality into the Method from the inception (QbD) and Validation helps to demonstrate that the desired Method is Fit For The Purpose. A Risk based strategy is needed to Develop and apply them for their intended purpose during the entire Life Cycle of such Methods" This presentation follows a progressive, time tested structure over the duration of 2 Days with a Breakout session for 2andHalf Hours on the 2nd Day, which involves Group participation,with real analytical problem solving and Method Development and generate an appropriate Validation schematics and the Validation Protocol.(From ACS site) Learn the fundamentals of quality assurance, quality control, and analytical methods validation and how to improve your FDA, WHO and OECD regulatory compliance directives for analytical data submissions.

Areas Covered in the Session: An overview of global compliance issues, global harmonization initiatives, role of ICH, relevance of Validation activities & the Paradigm ShiftQuality Control and Quality Assurance in Analytical, R&D, QC, PD laboratories: General considerations, Quality Systems, QC procedures, QA oversight, Process Control Measure.Perspectives of ICH, ISO Integration: ICH Q1 (Stability Studies), Q2 (Analytical Methods), Q3 (Impurities), Q7 (Pharma Process), Q9 (Risk Assessment), Q10 (Quality Systems), etc.Measurement, Measurement Uncertainty, Measurement Resolution, Total Error, BiasAnalytical Measurement: Process Model & Risk Assessment (REMS) in Methods Dev.A generic, science based outline of Methods Development & Validation [ab initio]Perspectives of QbD, PAT directives: online measurements /offline and the Paradigm Shift.Validation Parameters, their generic definitions and their practical applications.Highlights of the guidelines derived from International Standards - ISO 17025, AOAC, WHO, GLP, GMP, EMEA, USP/EP/JP, etc.Standardization/Qualification/Verification/Validation: the implicit continuumThe challenges in Methods Transfer, the premise of Co- Qualification.Some case histories and applications for improvement of Validation characteristicsData integrity and statistical evaluation of analytical data: SQC, control charts etc.Methods Development and Optimization in HPLC, UV-VIS including assessment of Peak Purity, as examples of the most recent techniques widely used in analytical laboratories.Phase Appropriate Validation & Regulatory submissions: IND/ ANDA/ NDA/ CMC.Preparation for Regulatory Inspections from FDA, EMA, WHO, ANVISA, etc, Who will benefit:ScientistsManagersR&D PersonnelQuality Assurance / Quality Control StaffValidation ManagersValidation CoordinatorsProduction and Process Development PersonnelRegulatory/Compliance ManagersChemistsTechnicians Study Directors(GLP)Qualified Persons (EMEA)Pharmaceutical DevelopmentCRO StaffCRO ManagersAccredited Laboratories in general, any one engaged with Test Methods.

Agenda: Day 1 Schedule Lecture 1:Quality Systems, Paradigm Shift, Global PerspectivesQA/QC Validation, Laboratory Controls(Sections I & II)Lecture 2:Risk Assessment, Strategy & Process ModelMeasurement Resolution, Errors and(Sections III & IV)Lecture 3:Rationale of Methods Development and Validation, A Generic Approach(Section V)Lecture 4:Guidelines of Method Development, Optimization and Validation Approaches [ab initio]Generic Definitions: Validation Parameters(Sections VI & VII)Q&A Day 2 Schedule Review of Parameters, Axioms & General PracticesLecture 1:Validation Guidelines: ICH, USP, Eurachem, AOAC, ISO 17025(Section VIII)Lecture 2:(CONT.) Validation Guidelines: ICH, USP, Eurachem, AOAC, ISO 17025(Section VIII)Lecture 3:Class Breakout Discussion - Group ExerciseLecture 4:Regulatory & Data RequirementsOptimization and Validation in HPLC(Sections IX & X) SpeakerShib MookherjeaSenior Director, ValQual International Shib Mookherjea is a globally acclaimed speaker and consultant and has extensive experience in R&D, quality assurance, and quality management and teaches Methods Development, Validation Procedures, and Conformity Assessment in the Analytical Laboratory; Qualification and Validation of Laboratory Instruments and Equipment for Regulatory and QS Compliance (IQ, OQ, PQ); and the webcast Cleaning Validation and Compliance Issues for Pharma, Biotech and Medical Device Industries.

Location: Baltimore, MD Date: April 5th & 6th, 2018 and Time: 9:00 AM to 6:00 PMVenue: The DoubleTree Baltimore-BWI AirportLocation : 890 Elkridge Landing Road - Linthicum, MD 21090 Price: Register now and save $200. (Early Bird)Price: $1,295.00 (Seminar Fee for One Delegate)Until February 28, Early Bird Price: $1,295.00 From March 01 to April 02, Regular Price: $1,495.00Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*Sponsorship Program benefits for "Quality Assurance Auditing for FDA Regulated Industry" seminarAt this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO's of various designations.

Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry. As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory-related industries and become known among these elite executives and subject matter experts.

Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants. For More Information- Contact us today! NetZealous LLC DBA Toll free: +1-800-447-9407Phone: +1-510-584-9661 Website: Registration Link - us on LinkedIn: us our Facebook page: us on Twitter:


The DoubleTree Baltimore-BWI Airport 890 Elkridge Landing Road - Linthicum,

Organizer Details

Conference organized by NetZealous LLC DBA GlobalCompliancePanel

Combination products are especially challenging to register and maintain since they consist of two or more regulated components covered by different and usually independent sets of regulations in both the EU and US and various other regions.

161 Mission Falls Lane,suite 216

Medical conference data provided by Meetings4Docs | Report a problem